Business · 22/12/2011Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Blood Establishment Registration and Product Listing
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, related to blood establishment registration and product listing.
Original source language: Federal Register — Health and Human ServicesOpen original release →